More evidence supports ventricular assist devices in complex angioplasty procedures

Original title: Percutaneous Left Ventricular Assist Device with Tandem Heart for High-Risk Percutaneous Coronary Intervention: The Mayo Clinic Experience. Reference: Oluseun O Alli, et al. Catheterization and Cardiovascular Intervention 80:728:734 There is a small group of poor surgical patients admitted for surgery that due to complex comorbidity, coronary anatomy and compromised left ventricular function that can be treated<a href="https://solaci.org/en/2012/12/17/more-evidence-supports-ventricular-assist-devices-in-complex-angioplasty-procedures/" title="Read more" >...</a>

Are reversal flow cerebral protection devices useful in carotid angioplasty?

Original title: Prospective, Multicenter European Study of the GORE Flor Reversal System for Providing Neuroprotection During Carotid Artery Stenting Reference: Dimitrios Nikas, et, al.Catheterization and Cardiovascular Intervention 80:1060-1068  Cerebral protection systems (CPS) have proved useful in carotid angioplasty stenting (CAS), although it is not clear what the advantages are in respect to carotid endarterectomy, except in high risk<a href="https://solaci.org/en/2012/12/12/are-reversal-flow-cerebral-protection-devices-useful-in-carotid-angioplasty/" title="Read more" >...</a>

Venous Angioplasty in Multiple Sclerosis

Original title: Disability caused by multiple sclerosis is associated with the number of extra cranial venous stenoses: possible improvement by venous angioplasty. Results of a prospective study. Reference: M Denislic et al. Phlebology, doi: 10.1258/phleb.2012.012065. Multiple Sclerosis (MS) is considered a chronic inflammatory disease, progressive and immuno-mediated, demyelinating of the central nervous system.  Its primary cause is still<a href="https://solaci.org/en/2012/12/07/venous-angioplasty-in-multiple-sclerosis/" title="Read more" >...</a>

Cilostazol reduces restenosis in infrapopliteal angioplasty

Original title: Impact of Cilostazol on Angiographic Restenosis after Balloon Angioplasty for Infrapopliteal Artery Disease in Patients with Critical Limb Ischemia Reference: Y. Soga et al. European Journal of Vascular and Endovascular Surgery 44 (2012) 577e581. Angioplasty is regularly used for patients with critical limb ischemia where restenosis is a great limitation, especially in infrapopliteal territory.  The use<a href="https://solaci.org/en/2012/11/30/cilostazol-reduces-restenosis-in-infrapopliteal-angioplasty/" title="Read more" >...</a>

Angioplasty for the erectile dysfunction

Original title: Zotarolimus-Eluting Peripheral Stents for the Treatment of Erectile Dysfunction in Subjects With Suboptimal Response to Phosphodiesterase-5 Inhibitors. Reference: Jason H. Rogers et al. J Am Coll Cardiol 2012. Article in press Up to 52% of men between 40 – 70 years old present some degree of erectile dysfunction, and 50% of these men get a suboptimal<a href="https://solaci.org/en/2012/11/30/angioplasty-for-the-erectile-dysfunction/" title="Read more" >...</a>

Complex angioplasty with ventricular assist

Original title: Real-Word of the Impella 2.5 Circulatory Support System in Complex High-Risk Percutaneous Coronary Intervention: The USpella Registry Reference: Brijeshwar maini, et al. Catheterization and Cardiovscular Intervention For about a decade angioplasty has begun to be performed in increasingly complex patients (PE) such as those with left coronary trunk injury, 3-vessel injury, poor ventricular function and surgically<a href="https://solaci.org/en/2012/11/29/complex-angioplasty-with-ventricular-assist/" title="Read more" >...</a>

Risk Score for carotid angioplasty

Original title: Risk Prediction for Adverse Events After Carotid Artery Stenting in Higher Surgical Risk Patients Reference: Neil J. Wimmer et al. 2012;43: 3218-3224 Stroke. There are many patients with high surgical risk for carotid endarterectomy, either because of unfavorable anatomy, comorbidities or both. In this situation carotid angioplasty is a therapeutic option. However, no score has been<a href="https://solaci.org/en/2012/11/28/risk-score-for-carotid-angioplasty/" title="Read more" >...</a>

Stent MGuard, primary angioplasty with a higher TIMI III

Original title: The MASTER Trial – Prospective, Randomized, Multicenter Evaluation of a Polyethylene Terephthalate Micronet Mesh–Covered Stent (MGuard) in ST-Segment Elevation Myocardial Infarction. Reference: Gregg W. Stone et. al. J Am Coll Cardiol 2012; 60: 1975-1984 Primary angioplasty has proven effective in restoring epicardial flow but myocardial perfusion is often suboptimal. One of the main mechanisms is distal<a href="https://solaci.org/en/2012/11/19/stent-mguard-primary-angioplasty-with-a-higher-timi-iii/" title="Read more" >...</a>

Revascularization Timing in Acute Coronary Syndrome

Multivessel disease is often present in ST elevation acute myocardial infarction (STEMI) patients. The AHA/ACC 2021 revascularization guidelines recommend staged complete revascularization as class I, single-setting complete revascularization as class 2b, and recommend against culprit only revascularization. At present, we have more randomized studies (BIOVASC, FIRE and MULTISTAR) comparing staged vs single-setting complete revascularization, but<a href="https://solaci.org/en/2024/07/16/revascularization-timing-in-acute-coronary-syndrome/" title="Read more" >...</a>

New Issue of SOLACI-LATAM Peripheral Registry in the European Medical Journal

We are proud to announce that the Latin American Society of Interventional Cardiology is sharing their latest issue of SOLACI-LATAM Peripheral Registry in the European Medical Journal. This way, SOLACI continues to contribute to advancing research on transcatheter intervention and treating peripheral artery disease across Latin America.  To be part of the SOLACI PERIPHERAL Registry<a href="https://solaci.org/en/2024/07/04/new-issue-of-solaci-latam-peripheral-registry-in-the-european-medical-journal/" title="Read more" >...</a>